Generation of TIM3 inhibitory single‑domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells
Liu Yang(Huazhong Agricultural University), Mingqian Feng(Huazhong Agricultural University)
Cited by 3
Related Papers
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth
|Journal for ImmunoTherapy of Cancer|2020|73